336 related articles for article (PubMed ID: 22788868)
1. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
[TBL] [Abstract][Full Text] [Related]
2. The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion.
Giachin G; Mai PT; Tran TH; Salzano G; Benetti F; Migliorati V; Arcovito A; Della Longa S; Mancini G; D'Angelo P; Legname G
Sci Rep; 2015 Oct; 5():15253. PubMed ID: 26482532
[TBL] [Abstract][Full Text] [Related]
3. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
4. Interaction of copper(II) with the prion peptide fragment HuPrP(76-114) encompassing four histidyl residues within and outside the octarepeat domain.
Di Natale G; Osz K; Nagy Z; Sanna D; Micera G; Pappalardo G; Sóvágó I; Rizzarell E
Inorg Chem; 2009 May; 48(9):4239-50. PubMed ID: 19348438
[TBL] [Abstract][Full Text] [Related]
5. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein.
Kenward AG; Bartolotti LJ; Burns CS
Biochemistry; 2007 Apr; 46(14):4261-71. PubMed ID: 17371047
[TBL] [Abstract][Full Text] [Related]
6. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake.
Miura T; Sasaki S; Toyama A; Takeuchi H
Biochemistry; 2005 Jun; 44(24):8712-20. PubMed ID: 15952778
[TBL] [Abstract][Full Text] [Related]
7. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
Rossetti G; Giachin G; Legname G; Carloni P
Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
[TBL] [Abstract][Full Text] [Related]
8. Difference in redox behaviors between copper-binding octarepeat and nonoctarepeat sites in prion protein.
Yamamoto N; Kuwata K
J Biol Inorg Chem; 2009 Nov; 14(8):1209-18. PubMed ID: 19585160
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry.
Davies P; Marken F; Salter S; Brown DR
Biochemistry; 2009 Mar; 48(12):2610-9. PubMed ID: 19196019
[TBL] [Abstract][Full Text] [Related]
10. Computational studies of Cu(II)[peptide] binding motifs: Cu[HGGG] and Cu[HG] as models for Cu(II) binding to the prion protein octarepeat region.
Pushie MJ; Rauk A
J Biol Inorg Chem; 2003 Jan; 8(1-2):53-65. PubMed ID: 12459899
[TBL] [Abstract][Full Text] [Related]
11. The dimeric and tetrameric octarepeat fragments of prion protein behave differently to its monomeric unit.
Valensin D; Luczkowski M; Mancini FM; Legowska A; Gaggelli E; Valensin G; Rolka K; Kozlowski H
Dalton Trans; 2004 May; (9):1284-93. PubMed ID: 15252619
[TBL] [Abstract][Full Text] [Related]
12. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.
Miura T; Hori-i A; Mototani H; Takeuchi H
Biochemistry; 1999 Aug; 38(35):11560-9. PubMed ID: 10471308
[TBL] [Abstract][Full Text] [Related]
13. Prion protein selectively binds copper(II) ions.
Stöckel J; Safar J; Wallace AC; Cohen FE; Prusiner SB
Biochemistry; 1998 May; 37(20):7185-93. PubMed ID: 9585530
[TBL] [Abstract][Full Text] [Related]
14. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.
Whittal RM; Ball HL; Cohen FE; Burlingame AL; Prusiner SB; Baldwin MA
Protein Sci; 2000 Feb; 9(2):332-43. PubMed ID: 10716185
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic and spectroscopic investigation on the role of Met residues in Cu(II) binding to the non-octarepeat site of the human prion protein.
Remelli M; Valensin D; Toso L; Gralka E; Guerrini R; Marzola E; Kozłowski H
Metallomics; 2012 Aug; 4(8):794-806. PubMed ID: 22791135
[TBL] [Abstract][Full Text] [Related]
16. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
17. De novo design of a copper(II)-binding helix-turn-helix chimera: the prion octarepeat motif in a new context.
Shields SB; Franklin SJ
Biochemistry; 2004 Dec; 43(51):16086-91. PubMed ID: 15610003
[TBL] [Abstract][Full Text] [Related]
18. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
[TBL] [Abstract][Full Text] [Related]
19. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches.
Todorova-Balvay D; Simon S; Créminon C; Grassi J; Srikrishnan T; Vijayalakshmi MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):75-82. PubMed ID: 15722047
[TBL] [Abstract][Full Text] [Related]
20. A Yin-Yang role for metals in prion disease.
Wong BS; Brown DR; Sy MS
Panminerva Med; 2001 Dec; 43(4):283-7. PubMed ID: 11677424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
